| UnitedHealthcare |
| Daytrana (methylphenidate) |
| Drugs for the Nervous System : Drugs for Attention Deficit Disorder |
- Prior Authorization: Hemophilia A (Factor VIII):
Duration: 1 year(s)
- 1. Approved Indications: a. Confirmed diagnosis of PAH (WHO Group l). Authorization Limit: Length of Benefit.
|